Personalized Nutrition Market to Quadruple to $60.92B by 2035

GlobeNewswire Inc.GlobeNewswire Inc.
|||5 min read
Key Takeaway

Global personalized nutrition market projected to reach $60.92 billion by 2035, growing 15% annually from $15.80 billion in 2025, driven by preventive healthcare awareness.

Personalized Nutrition Market to Quadruple to $60.92B by 2035

The Personalized Nutrition Boom Takes Center Stage

The global personalized nutrition market is poised for explosive growth, with projections showing the sector will expand nearly fourfold from USD 15.80 billion in 2025 to USD 60.92 billion by 2035. This anticipated expansion, driven by accelerating consumer awareness around preventive healthcare and demand for customized wellness solutions, represents a significant shift in how individuals approach nutrition and health management worldwide. The market's compound annual growth rate of 15.04% underscores the structural tailwinds supporting this emerging sector.

Market Size and Growth Projections

The transformation underway in personalized nutrition reflects fundamental changes in consumer behavior and technological innovation:

  • Global market value 2025: USD 15.80 billion
  • Projected market value 2035: USD 60.92 billion
  • Expected CAGR: 15.04% over the decade
  • U.S. market projection by 2035: USD 22.27 billion
  • U.S. CAGR: 15.11%

The United States market alone is expected to represent approximately 36.5% of the global market by 2035, reflecting the region's advanced healthcare infrastructure, high disposable income levels, and early adoption of digital health technologies. This regional concentration demonstrates the North American market's leadership position in personalized wellness innovation.

The scale of this projected expansion—nearly a 4x multiplier in market value over ten years—suggests investors and industry stakeholders are positioning personalized nutrition as a cornerstone of the broader digital health and preventive wellness ecosystem. The consistency of growth rates between the global and U.S. markets indicates relatively balanced expansion across developed economies.

Key Growth Drivers and Market Dynamics

Several interconnected factors are propelling the personalized nutrition sector's rapid expansion. Rising consumer awareness of preventive healthcare has fundamentally altered purchasing decisions, with individuals increasingly viewing targeted nutrition solutions as investments in long-term health rather than discretionary wellness purchases.

Chronic disease prevalence represents another critical catalyst. As populations worldwide grapple with rising rates of obesity, type 2 diabetes, cardiovascular disease, and metabolic disorders, consumers are seeking evidence-based, individualized approaches to nutrition that address their specific health conditions and genetic predispositions. Traditional one-size-fits-all dietary guidance is giving way to sophisticated, data-driven solutions tailored to individual metabolic profiles.

Technological innovation is fundamentally reshaping the market's capabilities:

  • DNA-based nutrition programs analyzing genetic variations to predict individual responses to specific nutrients and dietary patterns
  • AI-powered recommendation systems that process health data, lifestyle factors, and preferences to generate personalized meal plans and supplement protocols
  • Wearable integration enabling real-time tracking of nutritional intake and metabolic responses
  • Microbiome analysis informing gut-health optimization strategies tailored to individual bacterial composition

These technological capabilities are transitioning personalized nutrition from niche wellness offering to mainstream health intervention, supported by growing clinical evidence and partnerships with healthcare providers.

Market Context and Competitive Landscape

The personalized nutrition boom occurs within a broader transformation of the health and wellness sector. The global wellness market has experienced sustained growth over the past decade, but personalized nutrition represents one of the highest-growth segments due to its intersection of technology, healthcare, and consumer demand for customization.

Industry participants now range from established nutritional companies adapting their portfolios to pure-play personalized nutrition startups backed by venture capital. Telehealth platforms are integrating personalized nutrition services into their offerings, while large technology companies are exploring nutrition optimization as an extension of their health ecosystems. This competitive diversification suggests the market is still in early consolidation phases, with significant M&A activity likely as dominant platforms emerge.

Regulatory environments across major markets are evolving to accommodate personalized nutrition claims, though oversight remains fragmented. The FDA's framework for dietary supplements and the emerging regulatory approaches to nutrigenomics will shape competitive dynamics and market participation rules going forward.

Investor Implications and Strategic Significance

For investors, the personalized nutrition expansion presents multiple entry points across the value chain:

Technology and Data Companies: Businesses providing the AI algorithms, genetic analysis, and data integration infrastructure supporting personalized recommendations represent high-margin, scalable opportunities. As the sector matures, proprietary data advantages and network effects could create significant competitive moats.

Healthcare Integration: Companies successfully integrating personalized nutrition into clinical workflows or health insurance coverage models may achieve rapid scale, as shifting reimbursement toward preventive care accelerates.

Direct-to-Consumer Platforms: Established brands and emerging players capturing direct consumer relationships—through apps, subscription models, or integrated services—can leverage repeat purchasing and valuable health data assets.

Supply Chain and Ingredient Innovation: The projected growth in personalized nutrition likely creates demand for novel ingredients, bioavailable formulations, and precision manufacturing capabilities.

The 15% CAGR significantly outpaces broader consumer staples and even most pharmaceutical segments, making personalized nutrition attractive for growth-oriented investment portfolios. However, the market's early-stage maturity means competitive winners remain uncertain, and regulatory risks warrant careful monitoring.

The convergence of preventive healthcare economics—where personalized nutrition reduces long-term disease burden and healthcare costs—with technological enablement and consumer demand creates compelling fundamentals for sustained expansion. Insurance companies and healthcare systems increasingly recognize personalized nutrition's potential to improve outcomes while reducing expenses, creating revenue channels beyond direct consumer sales.

Looking Ahead

The personalized nutrition market's projected quadrupling by 2035 reflects a fundamental reshaping of how individuals approach health management and nutrition. As chronic disease prevalence increases and healthcare systems emphasize prevention, personalized, data-driven nutrition solutions are transitioning from luxury wellness offerings to essential health tools. The technology enabling these solutions continues advancing rapidly, while consumer awareness and acceptance accelerate.

For investors, financial professionals, and industry stakeholders, this expansion trajectory signals that personalized nutrition represents more than a temporary wellness trend—it reflects enduring shifts in healthcare delivery, consumer preferences, and technological capability. Companies that successfully navigate regulatory requirements, establish clinical credibility, and achieve scalable distribution models will likely emerge as dominant platforms in this rapidly expanding sector. The next decade will prove decisive in determining which participants capture sustainable competitive advantages in what promises to be one of healthcare's most dynamic growth markets.

Source: GlobeNewswire Inc.

Back to newsPublished Mar 3

Related Coverage

The Motley Fool

Healthcare's Dividend Gems: Why $ABBV and $BMY Stand Out for Income Investors

$ABBV and $BMY deliver above-average dividend yields and growth, standing out as rare healthcare sector exceptions for patient income investors navigating patent cliffs through innovation.

BMYCELGrABBV
GlobeNewswire Inc.

Danone Bolsters Functional Nutrition Play With Huel Acquisition

Danone acquires Huel to strengthen functional nutrition presence, combining the brand's DTC capabilities with global distribution scale.

DANOY
GlobeNewswire Inc.

Danone Acquires Huel to Strengthen Functional Nutrition Footprint

Danone acquires Huel to expand functional nutrition portfolio, combining direct-to-consumer expertise with global distribution capabilities.

DANOY
The Motley Fool

Two Defensive Healthcare Plays for Uncertain Markets: Abbott and Intuitive Surgical

Abbott Laboratories and Intuitive Surgical offer defensive healthcare positioning through diversification, dividend stability, and recurring revenue models amid market uncertainty.

ABTISRG
GlobeNewswire Inc.

SupplySide Connect Returns to NJ with 260+ Exhibitors Targeting Wellness Boom

SupplySide Connect New Jersey returns April 14-15, 2026, with 260+ exhibitors including ADM, Bayer, and Nestlé Health Science, showcasing wellness innovation trends.

KHCNSRGYADM
The Motley Fool

Abbott Labs Stock Slides 22% on Weak Diagnostics, But Dividend Investors See Opportunity

$ABT down 22% after disappointing earnings, but strong medical devices and $21B Exact Sciences deal offer recovery potential for income seekers.

ABTEXAS